However, since the expression of EGFR is much lower in A549 cells than other lung cancer cells [31], it is possible that PA-MSHA inhibit the activities of AKT or ERK of A549 through other pathways rather than EGFR signaling. The gene discussed is EGFR; the disease is lung cancer.